Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Manasi Pandurang Jogalekar


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jogalekar MP, Veerabathini A, Patel AB. COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development. Exp Biol Med (Maywood). 2021 Mar 23; 1535370221999989. PMID: 33757336.
    Citations:    Fields:    
  2. Rajendran RL, Jogalekar MP, Gangadaran P, Ahn BC. Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment. World J Stem Cells. 2020 Dec 26; 12(12):1492-1510. PMID: 33505597.
  3. Manivannan M, Jogalekar MP, Kavitha MS, Maran BAV, Gangadaran P. A mini-review on the effects of COVID-19 on younger individuals. Exp Biol Med (Maywood). 2021 02; 246(3):293-297. PMID: 33210552.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  4. Jogalekar MP, Veerabathini A, Gangadaran P. Recent developments in autophagy-targeted therapies in cancer. Exp Biol Med (Maywood). 2021 01; 246(2):207-212. PMID: 33167689.
    Citations:    Fields:    Translation:HumansAnimals
  5. Jogalekar MP, Veerabathini A, Gangadaran P. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions. Exp Biol Med (Maywood). 2020 06; 245(11):964-969. PMID: 32306751.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  6. Jogalekar MP, Serrano EE. Total RNA Isolation from Separately Established Monolayer and Hydrogel Cultures of Human Glioblastoma Cell Line. Bio Protoc. 2019 Jul 20; 9(14). PMID: 31528666.
    Citations: 1     
  7. Jogalekar MP, Serrano EE. Morphometric analysis of a triple negative breast cancer cell line in hydrogel and monolayer culture environments. PeerJ. 2018; 6:e4340. PMID: 29473000.
    Citations: 4     
  8. Jogalekar MP, Cooper LG, Serrano EE. Hydrogel Environment Supports Cell Culture Expansion of a Grade IV Astrocytoma. Neurochem Res. 2017 Sep; 42(9):2610-2624. PMID: 28589519.
    Citations: 3     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Jogalekar's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (28)
Co-Authors (1)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.